Skip to content

Tailored COVID-19 Testing Support Plan for Francophone African Born Immigrants

A Culturally Relevant Communication and Support Plan to Ensure Access to and Use of Covid-19 Testing for Francophone African Born Immigrants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05805163
Enrollment
100
Registered
2023-04-07
Start date
2023-09-30
Completion date
2024-05-31
Last updated
2023-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID19 Testing

Brief summary

The goal of this clinical trial is to test the effectiveness of a culturally sensitive COVID-19 testing intervention designed for Francophone (French speaking) African Born Immigrants (FABI) . The main question this study aims to answer is whether or not a a culturally sensitive COVID-19 educational pamphlet added to the home-based test will improve testing rates compared to receiving a standard home-based test alone.

Detailed description

Upon consenting, all participants will receive basic COVID-19 testing instructions from trained bilingual/bicultural Francophone African Born Immigrant (FABI) Community Health Workers (CHW's). Next, participants will be randomly assigned to either the control or intervention study arms. In the control condition (n=50) participants will receive a standard COVID-19 home-based test kit. In contrast, those assigned to the intervention condition (n=50) will receive the same COVID-19 home-based test kit plus a FABI culturally sensitive COVID-19 educational pamphlet. Lastly, (n=10) participants from each arm will be randomly selected to participate in qualitative interviews to assess their experiences with CHWs and their test kit.

Interventions

BEHAVIORALFABI tailored COVID-19 testing pamphlet

FABI adapted COVID-19 educational pamphlet

BEHAVIORALStandard COVID-19 home-based test kit

Standard COVID-19 home-based test kit

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Texas Woman's University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

FABI living in Dallas Fort Worth (DFW) -

Exclusion criteria

None \-

Design outcomes

Primary

MeasureTime frameDescription
Return rateTests returned within 3 monthsRatio of returned tests over total tests provided

Secondary

MeasureTime frameDescription
Qualitative assessment2 monthsQualitative assessment of experiences with CHWs, COVID-19 test kit, and FABI culturally sensitive COVID-19 educational pamphlet (if applicable)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026